Comparing Alzheimer’s Disease Subtypes Using PET and MRI
Author Information
Author(s): Wheatley Sophia H, Mohanty Rosaleena, Poulakis Konstantinos, Levin Fedor, Muehlboeck J Sebastian, Nordberg Agneta, Grothe Michel J, Ferreira Daniel, Westman Eric
Primary Institution: Karolinska Institutet
Hypothesis
The study aims to investigate the link between FDG-PET and MRI imaging modalities in identifying Alzheimer’s disease subtypes.
Conclusion
The study found distinct patterns of neurodegeneration in Alzheimer’s disease subtypes identified through FDG-PET and MRI, but these patterns were not consistent across both modalities.
Supporting Evidence
- Five hypometabolism- and atrophy-based subtypes were identified.
- Inter-modality comparisons showed that all FDG-PET subtypes displayed medial temporal atrophy.
- Allocations of FDG-PET and MRI subtypes were not consistent at an individual level.
Takeaway
Researchers looked at brain scans from people with Alzheimer’s to see how different types of brain damage show up on two different types of scans, and they found that the scans tell different stories about the same patients.
Methodology
The study used random forest hierarchical clustering on FDG-PET and MRI scans from patients to identify subtypes of Alzheimer’s disease.
Potential Biases
The study may be limited by mixed pathologies in participants that cannot be detected through neuroimaging alone.
Limitations
The study's cross-sectional design limits the ability to label patterns as subtypes over time, and the sample primarily included amnestic individuals, which may not represent all Alzheimer’s disease cases.
Participant Demographics
{"AD_dementia":{"count":180,"women_percentage":45,"average_age":74},"MCI":{"count":339,"women_percentage":43,"average_age":73},"cognitively_normal":{"count":176,"women_percentage":48,"average_age":75}}
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website